Nanobiotix SA banner

Intrinsic Value

0QAV price has not been updated for more than 2 years. This may indicate that the stock has been delisted.
Not Available for 0QAV

There is not enough data to reliably calculate the intrinsic value for Nanobiotix SA.

Do our valuations actually work? See backtest results .

Alternatives to 0QAV

Fundamental Analysis

What Nanobiotix Does

Biotechnology Health Care

Nanobiotix is a French biotechnology company focused on cancer treatment. Its main product is a nanoparticle-based therapy that is designed to be injected into a tumor and activated by radiotherapy, with the goal of making radiation kill more cancer cells while limiting damage to healthy tissue. The company is still building this into an approved medical business rather than selling a broad range of medicines.

Headquarters
France FR
Employees
100
IPO date
Oct 29, 2012
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months